Pulmonx Corporation LUNG Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $90.5M+8.0% | $83.79M+22.0% | $68.68M+28.0% | $53.66M+10.8% | ||
| $23.36M+7.2% | $21.79M+21.6% | $17.92M+29.9% | $13.8M+7.9% | ||
| $67.14M+8.3% | $62M+22.2% | $50.75M+27.3% | $39.87M+11.9% | ||
| 74.2%+0.2pp | 74%+0.1pp | 73.9%-0.4pp | 74.3%+0.7pp | ||
| $19.49M+10.9% | $17.57M-2.8% | $18.08M+17.4% | $15.4M+17.9% | ||
| $101.31M-0.8% | $102.14M+8.0% | $94.61M+13.8% | $83.11M+18.9% | ||
| $120.8M+0.9% | $119.71M+6.2% | $112.69M+14.4% | $98.5M+18.8% | ||
| $120.8M+0.9% | $119.71M+6.2% | $112.69M+14.4% | $98.5M+18.8% | ||
| -$53.66M+7.0% | -$57.7M+6.8% | -$61.93M-5.6% | -$58.64M-24.0% | ||
| -59.3%+9.6pp | -68.9%+21.3pp | -90.2%+19.1pp | -109.3%-11.6pp | ||
| $3.16M-10.0% | $3.51M+8.5% | $3.23M+203% | $1.07M+28.6% | ||
| $2.65M-47.6% | $5.06M-9.1% | $5.57M+264% | $1.53M+282% | ||
| $809K+216% | $256K+138% | -$673K— | —— | ||
| -$53.38M+4.5% | -$55.89M+7.3% | -$60.27M-2.9% | -$58.57M-21.2% | ||
| $626K+25.2% | $500K-12.4% | $571K+61.8% | $353K+2.9% | ||
| -$54M+4.2% | -$56.39M+7.3% | -$60.84M-3.3% | -$58.92M-21.1% | ||
| -59.7%+7.6pp | -67.3%+21.3pp | -88.6%+21.2pp | -109.8%-9.3pp | ||
| -$1.33+7.6% | -$1.44+10.0% | -$1.60-0.6% | -$1.59-17.8% | ||
| -$1.33+7.6% | -$1.44+10.0% | -$1.60-0.6% | -$1.59-17.8% | ||
| 162M+3.9% | 156M+3.0% | 151.5M+2.3% | 148.1M+2.8% | ||
| 162M+3.9% | 156M+3.0% | 151.5M+2.3% | 148.1M+2.8% | ||
| -$53.76M+5.6% | -$56.92M+4.8% | -$59.78M-1.2% | -$59.06M-21.4% | ||
| $809K+216% | $256K+138% | -$673K— | —— | ||
| $90.5M+8.0% | $83.79M+22.0% | $68.68M+28.0% | $53.66M+10.8% | ||
| -$53.66M+7.0% | -$57.7M+6.8% | -$61.93M-5.6% | -$58.64M-24.0% | ||
| -$52.61M+6.4% | -$56.21M+6.9% | -$60.39M-5.7% | -$57.12M-23.0% | ||
| -$52.61M+6.4% | -$56.21M+6.9% | -$60.39M-5.7% | -$57.12M-23.0% | ||
| -58.1%+9.0pp | -67.1%+20.8pp | -87.9%+18.5pp | -106.5%-10.5pp | ||
| -$53.66M+7.0% | -$57.7M+6.8% | -$61.93M-5.6% | -$58.64M-24.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pulmonx Corporation's revenue?
- Pulmonx Corporation (LUNG) generated $88.5M in revenue over the trailing twelve months, up 1.2% year over year.
- Is Pulmonx Corporation profitable?
- Pulmonx Corporation is not currently profitable: it reported a net loss of $53.2M over the trailing twelve months, a -60.1% net margin.
- What are Pulmonx Corporation's profit margins?
- Gross margin is 75.5% and operating margin is -58.8%, with a -60.1% net margin.
- What is Pulmonx Corporation's earnings per share?
- Pulmonx Corporation's diluted EPS over the trailing twelve months is $-1.30.
- Where does Pulmonx Corporation's income statement data come from?
- Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
